Luciano Marraffini

Fondatore presso Eligo Bioscience SA

Health Technology

Consumer Services

Health Services

Profilo

Luciano Marraffini is the founder of Intellia Therapeutics, Inc. (founded in 2014) and Eligo Bioscience SA (founded in 2014).
He holds a doctorate degree from The University of Chicago.

Posizioni attive di Luciano Marraffini

Società	Posizione	Inizio
Eligo Bioscience SA Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France.	Fondatore	01/05/2014

Tutte le posizioni attive di Luciano Marraffini

Precedenti posizioni note di Luciano Marraffini

Società	Posizione	Fine
INTELLIA THERAPEUTICS, INC.	Fondatore	-

Vedi nel dettaglio l'esperienza di Luciano Marraffini

Formazione di Luciano Marraffini

The University of Chicago

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Luciano Marraffini

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
INTELLIA THERAPEUTICS, INC.	Health Technology

Aziende private	1
Eligo Bioscience SA Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France.	Health Services